Cancer Clinical Trial - Pyxis 201
Cancer
Status:
RecruitingClinicalTrials.gov:
NCT05720117
A First-in-Human, Open-label, Multicenter, Phase 1 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of PYX-201 in Participants With Advanced Solid Tumors.